NO20041848L - Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater - Google Patents

Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater

Info

Publication number: NO20041848L
Authority: NO; Norway
Prior art keywords: mandible; salts; new; tetrahydrofuran derivatives; substituted tetracyclic
Prior art date: 2001-11-09

Application number

NO20041848A

Other languages

English (en)

Other versions

NO328548B1 (no

Inventor

Johannes Josephus Mari Willems

Bart Petrus Anna Maria Medaer

Sigrid Carl Maria Stokbroekx

Yves Georges Ruysschaert

Johan Erwin Edmond Weerts

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-09

Filing date

2004-05-05

Publication date

2004-05-05

2004-05-05 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2004-05-05 Publication of NO20041848L publication Critical patent/NO20041848L/no

2010-03-15 Publication of NO328548B1 publication Critical patent/NO328548B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)
Furan Compounds (AREA)

NO20041848A 2001-11-09 2004-05-05 Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater NO328548B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01204465		2001-11-09
PCT/EP2002/011136 WO2003040122A1 (en)	2001-11-09	2002-11-08	Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives

Publications (2)

Publication Number	Publication Date
NO20041848L true NO20041848L (no)	2004-05-05
NO328548B1 NO328548B1 (no)	2010-03-15

Family

ID=8181272

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20041848A NO328548B1 (no)	2001-11-09	2004-05-05	Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater

Country Status (25)

Country	Link
US (1)	US7317115B2 (no)
EP (1)	EP1446397B1 (no)
JP (1)	JP2005508988A (no)
KR (1)	KR100962325B1 (no)
CN (1)	CN1582282B (no)
AR (1)	AR037285A1 (no)
AT (1)	ATE299138T1 (no)
AU (1)	AU2002349327B2 (no)
BR (1)	BR0212770A (no)
CA (1)	CA2465043C (no)
DE (1)	DE60204982T2 (no)
EA (1)	EA006980B1 (no)
ES (1)	ES2244818T3 (no)
HR (1)	HRP20040395A2 (no)
HU (1)	HUP0402224A3 (no)
IL (2)	IL161866A0 (no)
MX (1)	MXPA04004365A (no)
MY (1)	MY128237A (no)
NO (1)	NO328548B1 (no)
NZ (1)	NZ531739A (no)
PL (1)	PL368456A1 (no)
TW (1)	TW200407117A (no)
UA (1)	UA79248C2 (no)
WO (1)	WO2003040122A1 (no)
ZA (1)	ZA200403454B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2335700A1 (en)	2001-07-25	2011-06-22	Boehringer Ingelheim (Canada) Ltd.	Hepatitis C virus polymerase inhibitors with a heterobicylic structure
BR0214068A (pt) *	2001-12-07	2004-10-13	Janssen Pharmaceutica Nv	Preparação de derivados 3,3a,8,12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b] furano transfundidos
WO2005013969A1 (en) *	2003-07-15	2005-02-17	Janssen Pharmaceutica N.V.	Antipsychotic agent with socializing properties
AU2005313325C1 (en)	2004-12-07	2011-11-10	Janssen Pharmaceutica N.V.	Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
US7915249B2 (en)	2005-01-27	2011-03-29	Janssen Pharmaceutical Nv	Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of CNS disorders
KR101299518B1 (ko)	2005-06-17	2013-08-29	얀센 파마슈티카 엔.브이.	사이클릭 아민 측쇄를 함유한 신규한 테트라사이클릭테트라하이드로푸란 유도체
US8765223B2 (en) *	2008-05-08	2014-07-01	Air Products And Chemicals, Inc.	Binary and ternary metal chalcogenide materials and method of making and using same
US8507040B2 (en)	2008-05-08	2013-08-13	Air Products And Chemicals, Inc.	Binary and ternary metal chalcogenide materials and method of making and using same
US8962675B1 (en) *	2013-09-12	2015-02-24	Abbvie Inc.	Atrasentan mandelate salts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3644462A1 (de)	1986-12-24	1988-07-07	Basf Ag	Verfahren zur herstellung von 5h-dibenzo(a,d)cyclohepten-5-onen
JP2656720B2 (ja) *	1992-12-09	1997-09-24	武田薬品工業株式会社	光学活性アミノクマラン誘導体
DK0750616T3 (da) *	1994-03-16	2001-07-23	Cenes Ltd	Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
BR9706639A (pt) *	1996-04-12	1999-01-12	Janssen Pharmaceutica Nv	Derivados de tetrahidrofurano tetracíclicos substituídos
CN1165291C (zh)	1996-05-20	2004-09-08	詹森药业有限公司	具有改进的生物利用度的抗真菌组合物
UA52778C2 (uk) *	1997-10-10	2003-01-15	Янссен Фармацевтика Н.В.	Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
US6281247B1 (en) *	1998-03-03	2001-08-28	Novo Nordisk A/S	Salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)amide
HUP9904624A2 (hu) *	1999-12-17	2002-01-28	Sanofi-Synthelabo	Szacharinszármazékok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és intermedierjeik
EP1186303A3 (en) *	2000-09-06	2003-12-10	Pfizer Products Inc.	Pharmaceutical combinations, for the treatment of stroke and traumatic brain injury, containing a neutrophil inhibiting factor and an selective NMDA-NR2B receptor antagonist

2002
- 2002-08-11 UA UA20040604168A patent/UA79248C2/uk unknown
- 2002-11-07 MY MYPI20024166A patent/MY128237A/en unknown
- 2002-11-08 US US10/491,799 patent/US7317115B2/en not_active Expired - Fee Related
- 2002-11-08 EP EP02781214A patent/EP1446397B1/en not_active Expired - Lifetime
- 2002-11-08 BR BR0212770-9A patent/BR0212770A/pt not_active IP Right Cessation
- 2002-11-08 EA EA200400656A patent/EA006980B1/ru not_active IP Right Cessation
- 2002-11-08 PL PL02368456A patent/PL368456A1/xx unknown
- 2002-11-08 WO PCT/EP2002/011136 patent/WO2003040122A1/en not_active Ceased
- 2002-11-08 TW TW091132840A patent/TW200407117A/zh unknown
- 2002-11-08 AU AU2002349327A patent/AU2002349327B2/en not_active Ceased
- 2002-11-08 CN CN02821918XA patent/CN1582282B/zh not_active Expired - Fee Related
- 2002-11-08 AR ARP020104298A patent/AR037285A1/es unknown
- 2002-11-08 KR KR1020047002379A patent/KR100962325B1/ko not_active Expired - Fee Related
- 2002-11-08 JP JP2003542168A patent/JP2005508988A/ja active Pending
- 2002-11-08 IL IL16186602A patent/IL161866A0/xx unknown
- 2002-11-08 HU HU0402224A patent/HUP0402224A3/hu unknown
- 2002-11-08 MX MXPA04004365A patent/MXPA04004365A/es active IP Right Grant
- 2002-11-08 AT AT02781214T patent/ATE299138T1/de not_active IP Right Cessation
- 2002-11-08 HR HR20040395A patent/HRP20040395A2/hr not_active Application Discontinuation
- 2002-11-08 DE DE60204982T patent/DE60204982T2/de not_active Expired - Lifetime
- 2002-11-08 CA CA2465043A patent/CA2465043C/en not_active Expired - Fee Related
- 2002-11-08 ES ES02781214T patent/ES2244818T3/es not_active Expired - Lifetime
- 2002-11-08 NZ NZ531739A patent/NZ531739A/en not_active IP Right Cessation
2004
- 2004-05-05 NO NO20041848A patent/NO328548B1/no not_active IP Right Cessation
- 2004-05-06 ZA ZA200403454A patent/ZA200403454B/en unknown
- 2004-05-06 IL IL161866A patent/IL161866A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
US20050085533A1 (en)	2005-04-21
ZA200403454B (en)	2005-08-31
CA2465043A1 (en)	2003-05-15
HUP0402224A3 (en)	2007-05-29
DE60204982T2 (de)	2006-04-27
EP1446397B1 (en)	2005-07-06
UA79248C2 (en)	2007-06-11
JP2005508988A (ja)	2005-04-07
MXPA04004365A (es)	2004-08-11
WO2003040122A1 (en)	2003-05-15
IL161866A (en)	2010-04-29
HRP20040395A2 (en)	2005-04-30
CN1582282B (zh)	2012-06-06
CN1582282A (zh)	2005-02-16
AU2002349327B2 (en)	2008-10-23
ATE299138T1 (de)	2005-07-15
DE60204982D1 (de)	2005-08-11
CA2465043C (en)	2011-02-15
KR100962325B1 (ko)	2010-06-11
AR037285A1 (es)	2004-11-03
EA006980B1 (ru)	2006-06-30
ES2244818T3 (es)	2005-12-16
KR20050044310A (ko)	2005-05-12
US7317115B2 (en)	2008-01-08
TW200407117A (en)	2004-05-16
MY128237A (en)	2007-01-31
HUP0402224A2 (hu)	2005-02-28
PL368456A1 (en)	2005-03-21
BR0212770A (pt)	2004-10-13
EP1446397A1 (en)	2004-08-18
NO328548B1 (no)	2010-03-15
NZ531739A (en)	2005-02-25
EA200400656A1 (ru)	2004-10-28
IL161866A0 (en)	2005-11-20

Publication	Publication Date	Title
DK2062898T3 (da)	2013-10-28	Spirocykliske cyclohexan-derivater
NO20043660L (no)	2004-10-12	Salter av valsartan
NO20050072L (no)	2005-02-03	Nye inhibitorer av kinaser
NO20044003L (no)	2004-10-14	Krystallisk mikronisat av tiotropiumbromid
ATE428701T1 (de)	2009-05-15	Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
SE0203693L (sv)	2004-06-14	Styrning av steriliseringsanordning
NO20010619D0 (no)	2001-02-06	Krystallin base av citalopram
ATE386730T1 (de)	2008-03-15	Phenylpiperazinderivate als serotonin wiederaufnahmehemmer
NO20024649L (no)	2002-09-27	Nye piperazinderivater
CY2017048I1 (el)	2018-09-05	Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
NO20042140L (no)	2004-07-22	Terapeutiske quionolonforbindelser med 5-HT anatagonistiske egenskaper
DK1697379T3 (da)	2009-07-20	Spirocykliske cyklohexan-derivater
NO20052474D0 (no)	2005-05-23	Amort form av esomeprazolsalter
NO20041848L (no)	2004-05-05	Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater
NO20040760L (no)	2004-02-20	Nye imidazopyridinforbindelser med terapeutisk virkning
NO20033408D0 (no)	2003-07-30	Fremgangsmåte for fremstilling av krystallinske nanopartikler
NO20035248D0 (no)	2003-11-26	Nye fenylalkyloksy-fenyl derivater
DK1534391T3 (da)	2007-06-11	Nye piperazinyl-pyrazinonderivater til behandling af 5-HT2A-recptor-relaterede forstyrrelser
NO20041370L (no)	2004-04-01	Nye vannfrie krystallinske former av gabapentin
DK1631575T3 (da)	2007-02-26	Nye 3-decladinosyl-9a-N-carbamoyl- og 9a-N-thiocarbamoylderivater af 9-deox-9-dihydro-9a-AZA-9A-homoerythromycin A
NO20051617D0 (no)	2005-03-31	Piperidinderivater av heterocyklusfusjonerte benzodioksaner med antidepressiv aktivitet
DE60200407D1 (de)	2004-06-03	Methylendioxy- Derivate
NO20025475L (no)	2003-01-15	Nye benzotiofenderivater
NO20035672L (no)	2003-12-18	Nye indolderivater
NO20050183L (no)	2005-01-12	Farmasoytiske salter av reboxetin

Legal Events

Date	Code	Title	Description
2012-05-21	CREP	Change of representative	Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA
2013-06-24	MM1K	Lapsed by not paying the annual fees